Dr. Cathleen Crudden awarded Chemical Institute of Canada 2027 CIC Medal

Dr. Cathleen Crudden, pictured in her lab at Queen's University, receives the award in recognition of a career marked by scientific innovation and international leadership in chemistry. Photography by Jennifer Roberts for Queen's Alumni Review.

C2MCI is pleased to announce that our Scientific Director, Dr. Cathleen Crudden, has been awarded the Chemical Institute of Canada’s 2027 CIC Medal. The CIC Medal is the highest honour awarded by the Chemical Institute of Canada, presented in recognition of Dr. Crudden’s outstanding contributions to chemistry in Canada.

Dr. Crudden’s successful career has led to scientific breakthroughs capable of building a better tomorrow: her use of N-heterocyclic carbenes (NHCs) ushered in a new standard for the chemistry behind self-assembled monolayer development, leading to breakthrough advances in corrosion prevention, microelectronics manufacturing, and nanomedicine.

The real-world impact of this discovery has attracted the attention of top semiconductor companies around the globe, advanced the development of NHC-stabilized nanoclusters for use in cancer therapies, and resulted in numerous patents and patent applications.

C2MCI is proud to see Dr. Crudden’s groundbreaking discoveries in chemistry and her leadership in the national and international chemistry communities celebrated through this achievement.

Read the full announcement via the Chemical Institute of Canada.